Our patient’s clinical picture, recurrent fever, mild splenomegaly, systemic inflammation, and elevated proinflammatory markers (IL-1β, IL-6, serum amyloid A), aligns with the phenotype of patients exhibiting complete loss of DOCK11 expression [2,3,5]. The gene discussed is DOCK11; the disease is Splenomegaly.